This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Oncotag Diagnostics Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Beom Jin Lim: Innovator in Bile Duct Cancer Diagnosis
Introduction
Beom Jin Lim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of cancer detection. His innovative approach has the potential to improve early diagnosis and treatment options for patients.
Latest Patents
Beom Jin Lim holds a patent for a method for diagnosing bile duct cancer using methionyl-tRNA synthetase in bile duct cells. This invention focuses on utilizing methionyl-tRNA synthetase (MRS) as a biomarker for identifying latent bile duct cancer in patients. The method aims to enhance the accuracy of cancer diagnosis, which is crucial for effective treatment.
Career Highlights
Throughout his career, Beom Jin Lim has been associated with Oncotag Diagnostics Co., Ltd., a company dedicated to advancing cancer diagnostics. His work has been instrumental in developing innovative solutions that address critical challenges in cancer detection.
Collaborations
Beom Jin Lim has collaborated with talented professionals in his field, including Sunghoon Kim and Nam Hoon Kwon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Beom Jin Lim's contributions to the field of cancer diagnostics exemplify the impact of innovation in healthcare. His patented method for diagnosing bile duct cancer represents a significant advancement that could lead to better patient outcomes.